Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P11021 (
BiP
)
2,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Spinocerebellar ataxia (SCA) is one of the most severe neurodegenerative diseases and is often associated with misfolded protein aggregates derived from the genetic mutation of related genes. Recently, mutations in
CD10
such as C143Y have been identified as SCA type 43.
CD10
, also known as neprilysin or neuroendopeptidase, digests functional neuropeptides, such as amyloid beta, in the extracellular region. In this study, we explored the cellular behavior of
CD10
C143Y to gain an insight into the functional relationship of the mutation and SCA pathology. We found that wild-type
CD10
is expressed on the plasma membrane and exhibits endopeptidase activity in a cultured cell line.
CD10
C143Y, however, forms a disulfide bond-mediated oligomer that does not appear by the wild-type
CD10
. Furthermore, the
CD10
C143Y mutant was retained in the endoplasmic reticulum (ER) by the molecular chaperone
BiP
and was degraded through the ER-associated degradation (ERAD) process, in which representative ERAD factors including EDEM1, SEL1L, and Hrd1 participate in the degradation. Suppression of
CD10
C143Y ERAD recovers intracellular transport but not enzymatic activity. Our results indicate that the C143Y mutation in
CD10
negatively affects protein maturation and results in ER retention and following ERAD. These findings provide beneficial insight into SCA type 43 pathology.
...
PMID:Endoplasmic Reticulum Associated Degradation of Spinocerebellar Ataxia-Related CD10 Cysteine Mutant. 3254 5